Company Directory / research
PrivateFor profitresearchBrisbane, Australia
Vaxxas
Vaxxass is a biotechnology company focused on needle-free vaccination technology.
- Founded
- 2011 15 years ago
- Staff
- 51-100 band, as listed
- Followers
- - on LinkedIn
- Funding
- $103M as listed, currency not stated
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed
Age
15 years old.
Reach
Website ranked #8,899,870 in the world for traffic, about 454 visits a month.
What it does
BiotechnologyHealth CareMedical Device
Funding, as listed
$103M currency not stated
- Rounds8
- LatestGrant, Aug 2023
- Investors10, 6 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Vaxxas, field by field. Contact details are held but never shown.
The company
- Name
- Vaxxas
- Type
- For profit
- Status
- Private
- Founded
- 2011
- Founders
- Mark Kendall
- Industry
- research
- Categories
- Biotechnology, Health Care, Medical Device
Where
- City
- Brisbane
- Country
- Australia
- Markets
- Asia-Pacific (APAC), Australasia
Size and reach
- Staff band
- 51-100
- Web traffic rank
- #8,899,870
- Monthly web visits
- 454
Funding, as listed
- Total
- 102,507,689 (currency not stated)
- Rounds
- 8
- Latest round
- Grant
- Latest round date
- Aug 2023
- Investors
- 10
- Lead investors
- 6
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Vaxxas may be growing as it has successfully completed a Phase I clinical trial for a measles and rubella vaccine delivered using its proprietary technology. The completion of this trial phase indicates progress in the company's product development pipeline. Furthermore, Vaxxas has plans for a Phase III trial in The Gambia, Africa, which suggests an expansion of its clinical research activities and potential growth in its operations. The successful trial and subsequent plans for further trials demonstrate a forward momentum in the company's clinical development efforts.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
research in Australia.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 128,574 companies in Australia and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.